The persistent male mortality disadvantage across virtually all human populations may reflect fundamental biological differences rather than simply lifestyle choices like smoking, risk-taking, or healthcare avoidance. This challenges the conventional wisdom that men's shorter lifespans stem primarily from modifiable behaviors. The analysis reveals that even after statistically controlling for behavioral, clinical, and sociodemographic variables, males maintain significantly higher mortality rates than females. This suggests intrinsic biological mechanisms may drive sex-based survival differences, potentially involving hormonal influences, genetic factors linked to the Y chromosome, or differential immune system responses. The finding carries profound implications for longevity research and public health strategy. If biology plays a larger role than previously recognized, interventions targeting male-specific physiological vulnerabilities could prove more effective than solely focusing on behavioral modifications. However, the observational nature of such analyses cannot definitively establish causation, and unmeasured confounding factors may still influence outcomes. The complexity of sex-based mortality patterns likely involves intricate interactions between genes, hormones, environmental exposures, and social factors that evolve differently across the lifespan. This research direction could reshape how we approach gender-specific health interventions, moving beyond traditional risk factor modification toward more targeted biological approaches. Understanding these fundamental differences may unlock new therapeutic pathways for extending male healthspan and reducing the mortality gap.